LIVE · UPDATED DAILY
I

ImmunityBio, Inc.

IBRXHealth Care· Upland, California, US
LAYOFFS TRACKED
9
LAST EVENT
Jan 30, 2026
MARKET CAP
$8.74B
as of Aug 26, 2026
EMPLOYEES
50

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing biologic products to treat and prevent cancer and infectious diseases by harnessing and modulating the immune system. The company develops cytokine and T-cell activating therapies as well as vaccine candidates, with a pipeline including cancer immunotherapies and biologics for infectious disease prevention.

Layoff history

EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS

Q4 '23Q1 '25Q1 '26Q3 '26

Layoff timeline

9 EVENTS
Jan 30, 2026WARN notice
Woburn, MA
Nov 17, 2025WARN notice
Halifax Co. VA
Jul 29, 2025WARN notice
Woburn, MA
Mar 25, 2025WARN notice
Culver City, CA · 2 locations
Mar 25, 2025WARN notice
Burlington, MA
Nov 25, 2024WARN notice
John Hopkins Court San Diego, CA · 5 locations
Oct 29, 2024WARN notice
S Douglas Street El Segundo, CA · 4 locations
Nov 16, 2023WARN notice
Dunkirk, NY
Oct 17, 2023WARN notice
Mariposa Avenue El Segundo, CA

Stories from here

No one has shared a story from ImmunityBio yet. Went through a layoff here? Your experience helps others feel less alone.

Share your story →

Get alerts for ImmunityBio

We'll email you the moment a new layoff is reported here.